August 2021
Ola Jeppsson has taken on a leading role as Business Development Director. In addition to his new role, he was appointed as a Chief Executive Officer at Biomapas Nordic AB starting August 2021.
Having a management and business development background in the life sciences industry, he brings years of experience and leadership to focus on evolving Biomapas growth. Representing and leading Biomapas Nordic AB as a Chief Executive Officer and a Business Development Director, Ola will guide the company’s expansion in the Nordics.
With a focus on key strategic areas, he will drive the development of Biomapas Phase 1 capabilities in Lithuania, steer the clinical research activities in core regions and grow the company’s operations throughout the Nordic countries.
“I am honoured to join the Biomapas Nordic AB as CEO and Business Development Director,” said Ola Jeppsson. “Biomapas has a strong position across Europe, CIS, EAEU and MENA regions and is well positioned for further growth in the Nordics. With my operational background and professional focus on efficient planning and execution of clinical trials, I look forward to providing Nordic clients with easy access to Biomapas outstanding capabilities for patient recruitment throughout different regions, as well as excellent Phase I services in Lithuania.”
“We are very excited to have Ola joining our Business Development team. He brings the right mixture of business, operational and managerial experience. I am sure that Ola will make a significant impact on our new business sales growth as well as on the overall expansion of the company, particularly in the Nordic region,” said Egle Pavyde, Head of Business Development.
Ola has over 25 years of experience working in the pharmaceutical industry and contract research organizations. From the start of his career, he has continued to pursue his career focused on clinical research. Over the years, Ola gained significant experience in operational management and project oversight in some of the largest CROs worldwide. Furthermore, he has become an expert in regional CRO management and business development. Before joining Biomapas Nordic AB, Ola was the Chief Executive Officer at IRW Consulting.
“Our clinical team is looking forward to strengthening Biomapas in the Nordics as well as in other countries where we have a strong presence and extensive experience. Ola Jeppsson brings years of experience in the life sciences industry, and with him joining Biomapas, we are confident that together we will explore many different opportunities to present modern clinical solutions.“ said Regina Auskalniene, Chief Global Clinical Research Officer.
“I am certain that the direct access to top recruiting countries throughout the world, combined with extended capabilities for local study management in the Nordics, will further establish Biomapas as a very attractive CRO for Nordic Sponsors,” shared Ola Jeppsson. “The number of interesting projects in clinical phase in Nordic companies is very impressive, and with the pandemic hopefully moving into a more stable phase, there could no better time to join the Biomapas team.”
About Ola Jeppsson
Ola Jeppsson has graduated with a Master’s in Pharmacy from Uppsala University. He jump-started his expertise path by specializing in Clinical Research and Clinical Team Leadership roles in Abbott Scandinavia, followed by Covance. His professional success materialized as he stepped into project management at Quintiles to lead clinical studies with sites worldwide, from Europe to the US, India, and many other countries.
Ola joined a Swedish CRO to become the driving force behind their largest project as a Clinical Research Manager and later was appointed to Director Clinical Operations & Project Management. He continued his career path in IRW Consulting with high management positions, leading him to become a Chief Executive Officer within the company. When IRW Consulting was acquired, he continued to hold his business development role while managing the company during the transition period.
About Biomapas
Biomapas is a functional and full outsourcing solution provider to the global life science industry. As a trusted partner for biopharmaceutical, medical device, cosmetics, and food supplement companies, we have one-stop-shop clinical research capabilities in high recruiting countries, delivering regulatory and pharmacovigilance excellence across Europe, CIS, EAEU and MENA regions through the entire product lifecycle. We ensure clients satisfaction by rapid, efficient and cost-effective working practices.
